Novanta to Present at the CJS Securities 19th Annual “New Ideas for the New Year” Institutional Investor Conference on Wednesday, January 9, 2019
BEDFORD, Mass.--(BUSINESS WIRE)--Jan 2, 2019--Novanta Inc. (Nasdaq: NOVT) (the “Company”), a trusted technology partner to medical and advanced technology equipment manufacturers, announced today that Matthijs Glastra, Chief Executive Officer, and Robert Buckley, Chief Financial Officer, are scheduled to present at the CJS Securities 19th Annual “New Ideas for the New Year” Institutional Investor Conference on Wednesday, January 9, 2019, in New York, NY.
Novanta is a leading global supplier of core technology solutions that give medical and advanced industrial original equipment manufacturers (“OEMs”) a competitive advantage. We combine deep proprietary technology expertise and competencies in photonics, vision and precision motion with a proven ability to solve complex technical challenges. This enables Novanta to engineer core components and sub-systems that deliver extreme precision and performance, tailored to our customers’ demanding applications. The driving force behind our growth is the team of innovative professionals who share a commitment to innovation and customer success. Novanta’s common shares are quoted on Nasdaq under the ticker symbol “NOVT”.
More information about Novanta is available on the Company’s website at www.novanta.com. For additional information, please contact Novanta Inc. Investor Relations at (781) 266-5137 or InvestorRelations@novanta.com.
View source version on businesswire.com:https://www.businesswire.com/news/home/20190102005427/en/
CONTACT: Novanta Inc.
Investor Relations Contact:
Robert J. Buckley
KEYWORD: UNITED STATES NORTH AMERICA CANADA MASSACHUSETTS NEW YORK
INDUSTRY KEYWORD: HEALTH BIOTECHNOLOGY MEDICAL DEVICES PROFESSIONAL SERVICES FINANCE
SOURCE: Novanta Inc.
Copyright Business Wire 2019.
PUB: 01/02/2019 11:01 AM/DISC: 01/02/2019 11:01 AM